Literature DB >> 26331830

Pathological vs. physiological cardiac hypertrophy.

Andreas N Kavazis1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26331830      PMCID： PMC4575564          DOI： 10.1113/JP271161

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  4 in total

Review 1.  Mechanisms of exercise-induced cardioprotection.

Authors:  Scott K Powers; Ashley J Smuder; Andreas N Kavazis; John C Quindry
Journal:  Physiology (Bethesda)       Date:  2014-01

2.  A prediction model for left ventricular mass in patients at high cardiovascular risk.

Authors:  Matthijs F L Meijs; Yvonne Vergouwe; Maarten J M Cramer; Evert-Jan A Vonken; Birgitta K Velthuis; David J Verton; Yolanda van der Graaf; Frank L Visseren; Willem P Mali; Pieter A Doevendans; Michiel L Bots
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2010-12

3.  Intermittent cardiac overload results in adaptive hypertrophy and provides protection against left ventricular acute pressure overload insult.

Authors:  Daniel Moreira-Gonçalves; Tiago Henriques-Coelho; Hélder Fonseca; Rita Ferreira; Ana Isabel Padrão; Cátia Santa; Sara Vieira; Ana Filipa Silva; Francisco Amado; Adelino Leite-Moreira; José Alberto Duarte
Journal:  J Physiol       Date:  2015-06-23       Impact factor: 5.182

Review 4.  The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy.

Authors:  Jenny Y Y Ooi; Bianca C Bernardo; Julie R McMullen
Journal:  Future Med Chem       Date:  2014-02       Impact factor: 3.808
  4 in total
  5 in total

1.  The TIR/BB-loop mimetic AS-1 prevents Ang II-induced hypertensive cardiac hypertrophy via NF-κB dependent downregulation of miRNA-143.

Authors:  Juan Song; Qifei Xie; Lin Wang; Yi Lu; Peijing Liu; Ping Yang; Rui Chen; Chen Shao; Chen Qiao; Zhongqun Wang; Jinchuan Yan
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

2.  Quantitative Non-canonical Amino Acid Tagging (QuaNCAT) Proteomics Identifies Distinct Patterns of Protein Synthesis Rapidly Induced by Hypertrophic Agents in Cardiomyocytes, Revealing New Aspects of Metabolic Remodeling.

Authors:  Rui Liu; Justin W Kenney; Antigoni Manousopoulou; Harvey E Johnston; Makoto Kamei; Christopher H Woelk; Jianling Xie; Michael Schwarzer; Spiros D Garbis; Christopher G Proud
Journal:  Mol Cell Proteomics       Date:  2016-08-09       Impact factor: 5.911

3.  Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.

Authors:  Sherif M Shoieb; Ayman O S El-Kadi
Journal:  Mol Cell Biochem       Date:  2020-06-12       Impact factor: 3.396

Review 4.  Multiple Levels of PGC-1α Dysregulation in Heart Failure.

Authors:  Shin-Ichi Oka; Amira D Sabry; Keiko M Cawley; Junco S Warren
Journal:  Front Cardiovasc Med       Date:  2020-01-30

5.  Comorbid CAD and ventricular hypertrophy compromise the perfusion of myocardial tissue at subcritical stenosis of epicardial coronaries.

Authors:  Eslam Abbas
Journal:  Egypt Heart J       Date:  2019-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.